V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009054 | 310003797 | null | 61.6 | Palliative (P) | 2015-06-29 | 2015-07-19 | CARBOPLATIN + GEMCITABINE | 02 | N | 310007587 | GEMCARBO |
| 310009055 | 310003797 | 1.76 | 80 | Palliative (P) | 2018-09-06 | 2018-09-22 | CHOP - 21 days | 02 | null | 310007587 | CHOP |
| 310009056 | 310003798 | 1.98 | 83.2 | Disease modification (D) | 2016-11-10 | 2017-01-19 | CHOP | N | N | 310007593 | CHOP |
| 310009057 | 310007555 | null | 61 | Palliative (P) | 2016-04-18 | 2016-04-22 | Liposomal Doxorubicin (Caelyx) | 02 | N | 310007610 | LIPOSOMAL DOXORUBICIN |
| 310009058 | 310003802 | null | 70.3 | null | 2017-05-14 | 2017-07-15 | CHOP - 21 days | 02 | N | 310007613 | CHOP |
| 310009059 | 310003804 | 1.7 | 83.3 | Palliative (P) | 2018-09-03 | 2018-09-19 | GEMCARBO | 02 | N | 310007616 | GEMCARBO |
| 310009060 | 310007558 | 1.54 | 61.9 | Neo-adjuvant (N) | null | 2015-08-04 | Bevacizumab | N | N | 310007646 | BEVACIZUMAB |
| 310009061 | 310003809 | 1.71 | 83 | Not known (9) | 2016-10-30 | 2018-01-26 | Bevacizumab 7.5mg/kg | N | N | 310007651 | BEVACIZUMAB |
| 310009062 | 310007560 | 1.8 | 77.2 | Palliative (P) | 2014-01-01 | 2014-01-03 | GEMCARBO | N | N | 310007651 | GEMCARBO |
| 310009063 | 310007561 | 1.81 | null | Not known (9) | 2016-03-14 | 2016-03-14 | CHOP - 21 days | N | N | 310007676 | CHOP |
| 310009064 | 310009529 | 1.63 | 71 | Palliative (P) | 2013-10-24 | 2013-11-05 | GemCarbo Days 1+8 | N | N | 310007685 | GEMCARBO |
| 310009065 | 310003815 | 1.56 | 95.2 | Palliative (P) | 2014-10-16 | 2014-11-01 | Trial Unspecified | Y | N | 310007695 | TRIAL |
| 310009066 | 310009530 | null | null | Curative (C) | 2018-03-25 | 2018-04-02 | CHOP - 21 days | N | N | 310007714 | CHOP |
| 310009067 | 310003817 | 1.84 | null | Palliative (P) | 2016-07-30 | 2016-08-03 | GEMCARBO | 2 | N | 310007768 | GEMCARBO |
| 310009068 | 310003821 | 1.63 | 77 | Curative (C) | 2017-04-28 | 2017-04-28 | Bevacizumab 15mg/kg | 02 | Y | 310007769 | BEVACIZUMAB |
| 310009069 | 310003821 | 1.61 | 95.1 | Palliative (P) | 2013-06-28 | 2013-11-23 | Bevacizumab 7.5mg/kg | 02 | null | 310007769 | BEVACIZUMAB |
| 310009070 | 310003821 | 1.5 | 66.8 | Curative (C) | 2016-09-18 | 2016-09-25 | CHOP - 21 days | N | N | 310007769 | CHOP |
| 310009072 | 310003827 | 1.57 | 78 | Curative (C) | 2018-06-15 | 2018-08-21 | CHOP - 21 days | 02 | N | 310007894 | CHOP |
| 310009073 | 310003831 | null | null | Neo-adjuvant (N) | 2015-08-09 | 2015-08-16 | GemCarbo Days 1+8 | N | null | 310007900 | GEMCARBO |
| 310009074 | 310003834 | 1.55 | 77 | Disease modification (D) | 2017-12-21 | 2017-12-29 | GEMCARBO | 02 | N | 310007919 | GEMCARBO |
| 310009077 | 310003837 | 1.67 | 77 | Palliative (P) | 2015-09-13 | 2015-09-27 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 310007961 | LIPOSOMAL DOXORUBICIN |
| 310009078 | 310007575 | 1.67 | 74 | Palliative (P) | 2015-08-22 | 2015-08-22 | Liposomal Doxorubicin 40mg/m2 | N | null | 310007985 | LIPOSOMAL DOXORUBICIN |
| 310009079 | 310011179 | 1.65 | 86 | Disease modification (D) | 2017-03-16 | 2017-03-30 | CHEMO-T TRIAL | N | N | 310007990 | TRIAL |
| 310009081 | 310003840 | 1.63 | 90.1 | Palliative (P) | 2016-11-11 | 2017-03-28 | Bevacizumab 7.5mg/kg | 02 | N | 310008024 | BEVACIZUMAB |
| 310009082 | 310007577 | 1.66 | 96.4 | Adjuvant (A) | 2014-05-03 | 2014-08-04 | Bevacizumab 7.5mg/kg | N | N | 310008039 | BEVACIZUMAB |
| 310009083 | 310003844 | 1.84 | 69.05 | Adjuvant (A) | 2016-07-14 | 2016-08-27 | Bevacizumab 7.5mg/kg | 99 | N | 310008048 | BEVACIZUMAB |
| 310009085 | 310010589 | 1.73 | 77.3 | Palliative (P) | 2017-01-27 | 2017-01-27 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 310008068 | LIPOSOMAL DOXORUBICIN |
| 310009086 | 310003846 | null | 73.2 | Curative (C) | 2015-04-07 | 2015-06-03 | CHOP - 21 days | N | N | 310008072 | CHOP |
| 310009088 | 310010591 | 1.73 | 78.5 | Palliative (P) | 2013-11-28 | 2013-11-28 | Bevacizumab 7.5mg/kg | N | N | 310008145 | BEVACIZUMAB |
| 310009089 | 310003849 | 1.8 | null | null | 2013-02-21 | 2013-03-03 | Bevacizumab 7.5mg/kg | N | N | 310008147 | BEVACIZUMAB |
| 310009090 | 310003851 | null | 74.4 | Palliative (P) | 2016-05-04 | 2016-10-21 | Trial Unspecified | N | N | 310008151 | TRIAL |
| 310009091 | 310009545 | 1.65 | 94.3 | Palliative (P) | null | 2015-04-15 | GemCarbo Days 1+8 | 02 | N | 310008168 | GEMCARBO |
| 310009092 | 310003854 | 1.53 | 65 | Curative (C) | 2015-08-17 | 2015-08-20 | CHOP - 21 days | N | N | 310008213 | CHOP |
| 310009093 | 310003856 | 1.63 | 82.2 | Palliative (P) | 2015-02-10 | 2015-02-11 | Trial Unspecified | N | Y | 310008217 | TRIAL |
| 310009094 | 310003859 | 1.84 | 65.7 | null | 2016-08-28 | 2016-08-28 | CHOP - 21 days | 2 | N | 310008309 | CHOP |
| 310009095 | 310003860 | 1.5 | 62.7 | Palliative (P) | 2017-12-26 | 2017-12-26 | Liposomal Doxorubicin 40mg/m2 | N | N | 310008309 | LIPOSOMAL DOXORUBICIN |
| 310009096 | 310003861 | 1.85 | 78.3 | Palliative (P) | 2013-01-28 | 2014-01-25 | Trial Unspecified | 02 | N | 310008318 | TRIAL |
| 310009097 | 310003862 | 1.65 | null | null | 2017-04-05 | 2017-09-14 | Bevacizumab 7.5mg/kg | N | N | 310008330 | BEVACIZUMAB |
| 310009098 | 310007589 | null | 73 | Disease modification (D) | 2015-01-19 | 2014-11-30 | CHOP - 21 days | null | N | 310008352 | CHOP |
| 310009099 | 310003866 | 1.69 | 75.2 | Palliative (P) | 2017-12-23 | 2017-12-28 | GemCarbo Days 1+8 | N | N | 310008352 | GEMCARBO |
| 310009100 | 310003868 | 1.63 | 59.4 | Palliative (P) | 2013-10-14 | 2013-10-14 | GemCarbo Days 1+8 | N | N | 310008397 | GEMCARBO |
| 310009101 | 310007593 | 1.89 | null | Palliative (P) | 2014-12-29 | 2015-01-07 | Liposomal Doxorubicin (Caelyx) | N | N | 310008435 | LIPOSOMAL DOXORUBICIN |
| 310009103 | 310003871 | null | 62.7 | Palliative (P) | 2017-03-24 | 2017-04-23 | Liposomal Doxorubicin (Myocet) | N | N | 310008462 | LIPOSOMAL DOXORUBICIN |
| 310009104 | 310003874 | 1.61 | 58.7 | Palliative (P) | 2015-06-20 | 2015-06-20 | Liposomal Doxorubicin 40mg/m2 | N | N | 310008466 | LIPOSOMAL DOXORUBICIN |
| 310009106 | 310003883 | 1.64 | 66.15 | Palliative (P) | 2014-10-10 | 2014-10-24 | Liposomal Doxorubicin (Caelyx) | N | N | 310008510 | LIPOSOMAL DOXORUBICIN |
| 310009108 | 310007602 | 1.73 | 78.7 | Palliative (P) | 2014-06-12 | 2014-06-16 | Liposomal Doxorubicin (20mg/m2) | 02 | N | 310008565 | LIPOSOMAL DOXORUBICIN |
| 310009109 | 310003891 | 1.6 | 67.5 | Palliative (P) | 2015-01-04 | 2015-01-04 | Bevacizumab 7.5mg/kg | 2 | N | 310008649 | BEVACIZUMAB |
| 310009110 | 310007604 | 1.64 | 47.9 | null | null | 2017-07-10 | GEMCARBO | N | null | 310008691 | GEMCARBO |
| 310009111 | 310003900 | 1.84 | 64.3 | Palliative (P) | null | 2016-05-25 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 310008727 | LIPOSOMAL DOXORUBICIN |
| 310009112 | 310003902 | 1.71 | 54.2 | Palliative (P) | 2016-01-19 | 2016-01-19 | Liposomal Doxorubicin (Caelyx) | N | N | 310008728 | LIPOSOMAL DOXORUBICIN |